ICCC Stock Analysis: Buy, Sell, or Hold?
ICCC - Immucell Corp
$10.89
-0.56 (-4.93%)
▼
5d:
+5.83%
30d:
+11.46%
90d:
+51.46%
HOLD
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 13, 2026
30d
Get Alerted When ICCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ICCC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ICCC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ICCC is currently trading at $10.89, which is considered extended relative to its 30-day fair value range of $9.47 to $10.49.
Technical Outlook: Technically, ICCC is in a strong uptrend. The price is approaching resistance at $10.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: ICCC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.00 (+28.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ICCC is in a strong uptrend. The price is approaching resistance at $10.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: ICCC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.00 (+28.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.47 -
$10.49
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 28.6% below Wall St target ($14.00)
Trading Range Analysis
30-Day Trading Range
$9.47 -
$10.49
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.29
Resistance Level
$10.75
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$14.00
(+28.6%)
Revenue Growth (YoY)
28.4%
Earnings Growth (YoY)
31.3%
Profit Margin
-1.8%
Share & Embed Analysis
Last updated: July 13, 2026 3:06 AM ET
Data refreshes hourly during market hours. Next update: 4:06 AM
Data refreshes hourly during market hours. Next update: 4:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$441 | 62 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 61 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 64 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 63 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 62 BUY |
